Psychotropic analgesic nitrous oxide for treating alcohol withdrawal in an outpatient setting - PubMed (original) (raw)
Comparative Study
Psychotropic analgesic nitrous oxide for treating alcohol withdrawal in an outpatient setting
R Ojutkangas et al. Int J Neurosci. 1994 May.
Abstract
In a retrospective study of 500 patients we present evidence that psychotropic analgesic nitrous oxide (PAN) can be used safely and successfully as an out-patient treatment for the AWS in the vast majority of cases. A feature of the PAN therapy is the rapidity of recovery of patients within 60 minutes; which is in stark contrast to that found when traditional benzodiazepine medication regimens are used. Our work confirms earlier findings confined to in-patients. Importantly, the requirements for addictive sedative medications is also dramatically reduced, greatly diminishing the dangers of secondary addiction. In a small number of cases PAN can be used to treat alcohol craving, which may prevent relapses through its positive effects on reducing craving. The promising, rapid anti-craving effects of PAN would seem to require further investigation to establish when it is likely to be of benefit in preventing relapse. In order to maximize the benefit of the PAN treatment to both patient and physician it is essential for the physician to undergo a short hands-on training course.
Similar articles
- Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco.
Daynes G, Gillman MA. Daynes G, et al. Int J Neurosci. 1994 May;76(1-2):13-6. doi: 10.3109/00207459408985987. Int J Neurosci. 1994. PMID: 7960461 - Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state.
Lichtigfeld FJ, Gillman MA. Lichtigfeld FJ, et al. Int J Neurosci. 1994 May;76(1-2):17-33. doi: 10.3109/00207459408985988. Int J Neurosci. 1994. PMID: 7960465 Review. - Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.
Gillman MA, Lichtigfeld FJ, Young TN. Gillman MA, et al. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005190. doi: 10.1002/14651858.CD005190.pub2. Cochrane Database Syst Rev. 2007. PMID: 17443576 Review. - Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal.
Lichtigfeld FJ, Gillman MA. Lichtigfeld FJ, et al. Clin Neuropharmacol. 1996 Jun;19(3):246-51. doi: 10.1097/00002826-199619030-00006. Clin Neuropharmacol. 1996. PMID: 8726543 Review. - The initial management of alcoholism using oxygen and nitrous oxide: a transcultural study.
Daynes G. Daynes G. Int J Neurosci. 1989 Nov;49(1-2):83-6. doi: 10.3109/00207458909087042. Int J Neurosci. 1989. PMID: 2606608
Cited by
- What is better for psychiatry: Titrated or fixed concentrations of nitrous oxide?
Gillman MA. Gillman MA. Front Psychiatry. 2022 Aug 22;13:773190. doi: 10.3389/fpsyt.2022.773190. eCollection 2022. Front Psychiatry. 2022. PMID: 36072452 Free PMC article. - Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry.
Gillman MA. Gillman MA. Curr Drug Res Rev. 2019;11(1):12-20. doi: 10.2174/1874473711666181008163107. Curr Drug Res Rev. 2019. PMID: 30829177 Free PMC article. Review. - Recommended drug treatment strategies for the alcoholic patient.
Schaffer A, Naranjo CA. Schaffer A, et al. Drugs. 1998 Oct;56(4):571-85. doi: 10.2165/00003495-199856040-00005. Drugs. 1998. PMID: 9806104 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical